A large language model for risk-of-bias assessment in systematic reviews of prognosis studies in clinical neurology

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Risk-of-bias (ROB) assessments represent an integral component of systematic reviews. However, this task is often highly repetitive, time-consuming, and may lack inter-rater consistency. Large language models (LLMs) offer opportunities for automation in systematic reviews, which may expedite and enhance the quality and consistency of research synthesis. Methods: Using zero-shot prompting, we designed an LLM-based pipeline as a virtual mimic of a human reviewer for the Quality in Prognosis Studies (QUIPS) framework. Then, focusing on prognostic research in a single discipline (neurology), we applied this pipeline to articles included in previously published systematic reviews. We studied inter-rater agreement between both (1) the LLM and the original human ROB assessments and (2) between original human ROB assessments. Results: 298 articles from 15 reviews across three domains (epilepsy, traumatic brain injury, stroke) were included. We demonstrate the feasibility of a tailored, prompt-engineered LLM pipeline for automating ROB assessments with the QUIPS tool. While LLM-human agreement was limited (Cohen's weighted kappa; = 0.22, 95% CI, 0.12 - 0.33), our data tentatively suggest, based on a small sample (n=5), that it may not be inferior to human-human agreement (Cohen's weighted kappa; = -0.25, 95% CI, -1.04 - 0.54). Wilcoxon signed-rank tests were statistically significant (p < 0.05) across four bias domains and for the overall risk scores, and rank-biserial correlations demonstrated human raters' tendency to assign higher risk scores than LLM counterparts. Conclusions: With targeted methodological refinements - including standardization of QUIPS implementation and validation against expert ratings - automated ROB assessments may meaningfully reduce time and cost of systematic reviews of prognosis studies in neurology and beyond.

Article activity feed